Lupin Limited

Lupin is an innovation led transnational pharmaceutical company with presence in over 100 countries and turnover of US $ 3 billion. We focus on development of difficult to develop, specialty and niche generics in the fields of CNS, anti-infectives, respiratory, CVS, urology, pain and diabetes. With continued investments towards internalizing technology platforms in the fields of biotechnology, complex/long acting injectables, inhalation, Lupin is well positioned to become a global pharmaceutical powerhouse with a broad specialty portfolio.